MKRN3 and polycystic ovary syndrome: Given our present study is the first to report MKRN3 nonsense mutation in a CPP girl, who also has obese companied with IGT, weight management and the long-term follow-up was still needed in order to monitor the adverse health outcomes, especially for the PCOS in later life.